Dr Mikyung Kelly Seo

University of Cambridge

University departments: 
Department of Public Health and Primary Care

Position: Research Associate
Personal home page:

PubMed journal articles - click here

Research Programme or Virtual Institute: 
Early Cancer Institute
Secondary Programme: 
Pancreatic Cancer
ks2024
Recent publications:
 Retrieving latest data from feed...

Symplectic Elements feed provided by Research Information, University of Cambridge


Key publications: 

Seo, Mikyung Kelly. "Has the development of cancer biomarkers to guide treatment improved health outcomes?." The European Journal of Health Economics (2021): 1-22.

Seo, Mikyung Kelly, et al. "HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?." PharmacoEconomics-open 4.3 (2020): 529-539.

Seo, Mikyung Kelly, and John Cairns. "Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer." PloS one 13.9 (2018): e0204496.

Seo, Mikyung Kelly, Peter Baker, and Karen Ngoc-Lan Ngo. "Cost-effectiveness analysis of vaccinating children in Malawi with RTS, S vaccines in comparison with long-lasting insecticide-treated nets." Malaria Journal 13.1 (2014): 1-11.

Blanchard, A., and R. Strand, M.K. Seo, et al. "Cancer biomarkers: Ethics, economics and society." (2017). DOI: 10.24994/2018/b.biomarkers 

Micocci M, Gordon AL, Seo MK, et al. "Is Point-of-Care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a Point-of-Care Polymerase Chain Reaction test for SARS-COV-2." Age Ageing. 2021 Apr 21:afab072. DOI: 10.1093/ageing/afab072. PMID: 33884411; PMCID: PMC8083194.